LifeStance Health (LFST) Accumulated Depreciation & Amortization (2020 - 2026)

LifeStance Health (LFST) has 7 years of Accumulated Depreciation & Amortization data on file, last reported at $10.4 million in Q1 2026.

• Quarterly Accumulated Depreciation & Amortization rose 0.74% year-over-year to $10.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.4 million (up 0.74% YoY) and the FY2025 annual result came in at $41.6 million, up 2.32% from the prior year.
• Accumulated Depreciation & Amortization retreated to $10.4 million in Q1 2026 per LFST's latest filing, from $41.6 million in the prior quarter.
• Across five years, Accumulated Depreciation & Amortization topped out at $41.6 million in Q4 2025 and bottomed at $5.7 million in Q1 2022.
• The 5-year median for Accumulated Depreciation & Amortization is $12.5 million (2022), against an average of $19.2 million.
• The widest annual swing landed in 2022, when Accumulated Depreciation & Amortization soared 408.37%; it then slumped 53.13% in 2023.
• Tracing LFST's Accumulated Depreciation & Amortization over 5 years: stood at $28.9 million in 2022, then gained by 29.23% to $37.4 million in 2023, then rose by 8.84% to $40.7 million in 2024, then advanced by 2.32% to $41.6 million in 2025, then plunged by 75.09% to $10.4 million in 2026.
• Per Business Quant, the three latest LFST Accumulated Depreciation & Amortization figures stand at $10.4 million (Q1 2026), $41.6 million (Q4 2025), and $31.3 million (Q3 2025).

Peer Comparison